State Street’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.58M | Buy |
82,142
+983
| +1% | +$30.8K | ﹤0.01% | 3219 |
|
2025
Q1 | $2.41M | Buy |
81,159
+3,894
| +5% | +$116K | ﹤0.01% | 3173 |
|
2024
Q4 | $2.28M | Buy |
77,265
+594
| +0.8% | +$17.5K | ﹤0.01% | 3279 |
|
2024
Q3 | $2.39M | Buy |
76,671
+29,897
| +64% | +$931K | ﹤0.01% | 3266 |
|
2024
Q2 | $1.59M | Buy |
46,774
+1,328
| +3% | +$45K | ﹤0.01% | 3389 |
|
2024
Q1 | $2.95M | Buy |
45,446
+1,920
| +4% | +$125K | ﹤0.01% | 3139 |
|
2023
Q4 | $2.97M | Buy |
43,526
+1,160
| +3% | +$79.3K | ﹤0.01% | 3172 |
|
2023
Q3 | $2.2M | Buy |
42,366
+1,512
| +4% | +$78.5K | ﹤0.01% | 3288 |
|
2023
Q2 | $2.45M | Buy |
40,854
+1,688
| +4% | +$101K | ﹤0.01% | 3316 |
|
2023
Q1 | $1.94M | Buy |
39,166
+2,936
| +8% | +$145K | ﹤0.01% | 3352 |
|
2022
Q4 | $2.07M | Buy |
36,230
+27,279
| +305% | +$1.56M | ﹤0.01% | 3365 |
|
2022
Q3 | $420K | Sell |
8,951
-2,883
| -24% | -$135K | ﹤0.01% | 3842 |
|
2022
Q2 | $442K | Buy |
+11,834
| New | +$442K | ﹤0.01% | 3881 |
|
2022
Q1 | – | Sell |
-6,316
| Closed | -$216K | – | 4922 |
|
2021
Q4 | $216K | Buy |
6,316
+116
| +2% | +$3.97K | ﹤0.01% | 4315 |
|
2021
Q3 | $230K | Buy |
+6,200
| New | +$230K | ﹤0.01% | 4304 |
|